HUS1600064I1 - Timidin kináz - Google Patents

Timidin kináz

Info

Publication number: HUS1600064I1
Authority: HU; Hungary
Prior art keywords: thymidine kinase; nucleotides; splice; polynucleotide; altered
Prior art date: 2004-06-18

Application number

HUS1600064C

Other languages

English (en)

Original Assignee

Molmed Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-18

Filing date

2016-12-30

Publication date

2017-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32750189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUS1600064(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-12-30 Application filed by Molmed Spa filed Critical Molmed Spa

2017-02-28 Publication of HUS1600064I1 publication Critical patent/HUS1600064I1/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
- C12N9/1211—Thymidine kinase (2.7.1.21)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Oncology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Plant Pathology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Physics & Mathematics (AREA)
Urology & Nephrology (AREA)
Virology (AREA)
Biophysics (AREA)
Hematology (AREA)
Cardiology (AREA)
Transplantation (AREA)
Pulmonology (AREA)

HUS1600064C 2004-06-18 2016-12-30 Timidin kináz HUS1600064I1 (hu)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0413702.2A GB0413702D0 (en)	2004-06-18	2004-06-18	Thymidine kinase
EP05766582A EP1781789B1 (en)	2004-06-18	2005-06-17	Thymidine kinase

Publications (1)

Publication Number	Publication Date
HUS1600064I1 true HUS1600064I1 (hu)	2017-02-28

Family

ID=32750189

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HUS1600064C HUS1600064I1 (hu)	2004-06-18	2016-12-30	Timidin kináz

Country Status (20)

Country	Link
US (5)	US8357788B2 (hu)
EP (1)	EP1781789B1 (hu)
JP (1)	JP5091669B2 (hu)
KR (1)	KR101337210B1 (hu)
CN (1)	CN101010428B (hu)
AT (1)	ATE520779T1 (hu)
AU (1)	AU2005254807B2 (hu)
CA (1)	CA2569304C (hu)
CY (2)	CY1111925T1 (hu)
DK (1)	DK1781789T3 (hu)
ES (1)	ES2372022T3 (hu)
GB (1)	GB0413702D0 (hu)
HU (1)	HUS1600064I1 (hu)
IL (2)	IL179660A (hu)
LT (1)	LTC1781789I2 (hu)
NL (1)	NL300856I2 (hu)
PL (1)	PL1781789T3 (hu)
PT (1)	PT1781789E (hu)
SI (1)	SI1781789T1 (hu)
WO (1)	WO2005123912A2 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0413702D0 (en)	2004-06-18	2004-07-21	Molmed Spa	Thymidine kinase
RU2607044C2 (ru)	2011-10-05	2017-01-10	МОЛМЕД СпА	Система очистки вирусных векторов
JP7047238B2 (ja)	2017-12-28	2022-04-05	バイオノックスインコーポレイテッド	安全性及び抗がん効果が改善した腫瘍溶解性ウイルス
US11157042B1 (en)	2018-03-28	2021-10-26	Douglas Patton	Systems and methods for interaction of wearable communication devices
US12304962B2 (en)	2018-05-30	2025-05-20	Glycostem Therapeutics B.V.	CAR NK cells
US20220202885A1 (en) *	2019-06-27	2022-06-30	Bionoxx Inc.	Oncolytic virus with improved safety and anticancer effects
WO2025168661A1 (en)	2024-02-05	2025-08-14	Ospedale San Raffaele S.R.L.	Chimeric antigen receptor

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69032841T2 (de)	1989-01-23	1999-05-12	Chiron Corp., Emeryville, Calif.	Rekombinante zellen für therapien von infektionen und hyperprolieferative störungen und deren herstellung
JP2752788B2 (ja)	1989-01-23	1998-05-18	カイロンコーポレイション	感染および過剰増殖障害の為の組換え療法
US5631236A (en)	1993-08-26	1997-05-20	Baylor College Of Medicine	Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
IT1261847B (it)	1993-09-01	1996-06-03	San Romanello Centro Fond	Metodo per marcare cellule eucariote.
FR2712603B1 (fr)	1993-11-18	1996-02-09	Centre Nat Rech Scient	Virus recombinants, préparation et utilisation en thérapie génique.
WO1995030007A1 (en)	1994-05-02	1995-11-09	University Of Washington	Thymidine kinase mutants
FR2744731B1 (fr)	1996-02-09	1998-05-22	Rhone Poulenc Rorer Sa	Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
FR2751988B1 (fr)	1996-08-01	1998-09-11	Rhone Poulenc Rorer Sa	Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
IL125597A0 (en) *	1996-02-09	1999-03-12	Rhone Poulenc Rorer Sa	Variants of thymidine kinase related nucleic acids sequences and their use in genic therapy
WO1997037542A1 (en)	1996-04-10	1997-10-16	University Of Southern California	Gene therapy for proliferative vitreoretinopathy
EP1886677A1 (en)	1996-07-26	2008-02-13	Susan P. Perrine	Use of an inducing agent for the treatment of blood, viral and cellular disorders
JP2002516061A (ja)	1997-10-14	2002-06-04	ダーウィンモレキュラーコーポレイション	チミジンキナーゼ変異体ならびにチミジンキナーゼ活性およびグアニル酸キナーゼ活性を有する融合タンパク質
GB0008966D0 (en) *	2000-04-13	2000-05-31	Imp College Innovations Ltd	Vectors for gene therapy
CN1273587C (zh) *	2002-06-05	2006-09-06	上海新世界基因技术开发有限公司	疱疹病毒胸苷激酶突变体及其应用
DE50213745D1 (de)	2002-12-09	2009-09-17	Celltech Gmbh Biotechnologie	Verbesserte retrovirale Vektoren für die Gentherapie
GB0413702D0 (en)	2004-06-18	2004-07-21	Molmed Spa	Thymidine kinase

2004
- 2004-06-18 GB GBGB0413702.2A patent/GB0413702D0/en not_active Ceased
2005
- 2005-06-17 DK DK05766582.0T patent/DK1781789T3/da active
- 2005-06-17 ES ES05766582T patent/ES2372022T3/es not_active Expired - Lifetime
- 2005-06-17 PT PT05766582T patent/PT1781789E/pt unknown
- 2005-06-17 AU AU2005254807A patent/AU2005254807B2/en not_active Ceased
- 2005-06-17 CA CA2569304A patent/CA2569304C/en not_active Expired - Fee Related
- 2005-06-17 WO PCT/IB2005/002358 patent/WO2005123912A2/en not_active Ceased
- 2005-06-17 KR KR1020077001055A patent/KR101337210B1/ko not_active Expired - Fee Related
- 2005-06-17 US US11/629,962 patent/US8357788B2/en not_active Expired - Fee Related
- 2005-06-17 SI SI200531385T patent/SI1781789T1/sl unknown
- 2005-06-17 JP JP2007516075A patent/JP5091669B2/ja not_active Expired - Fee Related
- 2005-06-17 AT AT05766582T patent/ATE520779T1/de active
- 2005-06-17 EP EP05766582A patent/EP1781789B1/en not_active Expired - Lifetime
- 2005-06-17 CN CN2005800286686A patent/CN101010428B/zh not_active Expired - Fee Related
- 2005-06-17 PL PL05766582T patent/PL1781789T3/pl unknown
2006
- 2006-11-28 IL IL179660A patent/IL179660A/en active IP Right Grant
2011
- 2011-05-24 IL IL213084A patent/IL213084A0/en unknown
- 2011-10-10 CY CY20111100964T patent/CY1111925T1/el unknown
2012
- 2012-08-31 US US13/601,174 patent/US8642311B2/en not_active Expired - Lifetime
2013
- 2013-12-10 US US14/101,704 patent/US9005945B2/en not_active Expired - Fee Related
2015
- 2015-04-01 US US14/676,696 patent/US10155052B2/en not_active Expired - Fee Related
2016
- 2016-12-28 LT LTPA2016047C patent/LTC1781789I2/lt unknown
- 2016-12-28 CY CY2016054C patent/CY2016054I1/el unknown
- 2016-12-29 NL NL300856C patent/NL300856I2/nl unknown
- 2016-12-30 HU HUS1600064C patent/HUS1600064I1/hu unknown
2018
- 2018-11-15 US US16/192,224 patent/US10314925B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1781789B1 (en)	2011-08-17
US20150231275A1 (en)	2015-08-20
NL300856I2 (hu)	2017-04-20
IL179660A (en)	2012-12-31
US10314925B2 (en)	2019-06-11
AU2005254807B2 (en)	2011-08-18
US20190070312A1 (en)	2019-03-07
SI1781789T1 (sl)	2012-03-30
IL213084A0 (en)	2011-07-31
CY1111925T1 (el)	2015-11-04
EP1781789A2 (en)	2007-05-09
US20130028876A1 (en)	2013-01-31
WO2005123912A3 (en)	2006-05-04
JP5091669B2 (ja)	2012-12-05
WO2005123912A2 (en)	2005-12-29
CY2016054I2 (el)	2017-07-12
CA2569304C (en)	2014-08-12
US8357788B2 (en)	2013-01-22
IL179660A0 (en)	2007-05-15
ES2372022T3 (es)	2012-01-13
JP2008502342A (ja)	2008-01-31
US10155052B2 (en)	2018-12-18
CN101010428A (zh)	2007-08-01
CY2016054I1 (el)	2017-07-12
PT1781789E (pt)	2011-10-20
HK1097881A1 (en)	2007-07-06
US20140178345A1 (en)	2014-06-26
LTPA2016047I1 (lt)	2017-01-25
KR20070032786A (ko)	2007-03-22
GB0413702D0 (en)	2004-07-21
PL1781789T3 (pl)	2011-12-30
AU2005254807A1 (en)	2005-12-29
DK1781789T3 (da)	2011-11-28
US9005945B2 (en)	2015-04-14
ATE520779T1 (de)	2011-09-15
KR101337210B1 (ko)	2013-12-06
US8642311B2 (en)	2014-02-04
US20090130069A1 (en)	2009-05-21
CN101010428B (zh)	2013-10-02
CA2569304A1 (en)	2005-12-29
LTC1781789I2 (lt)	2018-10-10

Publication	Publication Date	Title
HUS1600064I1 (hu)	2017-02-28	Timidin kináz
GB0909600D0 (en)	2009-07-15	Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
AU2003262906A8 (en)	2004-03-19	Bioreactors with multiple chambers
WO2010018577A3 (en)	2010-08-19	Data entry system
WO2008087561A8 (en)	2008-10-09	Methods and compositions for modulating the sirna and rna-directed-dna methylation pathways
ATE430589T1 (de)	2009-05-15	Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
DE602006015405D1 (de)	2010-08-26	Inkrementelle Assoziation von Metadaten zu Produktionsdaten
MY139743A (en)	2009-10-30	(2-carboxamido)(3-amino) thiophene compounds
CY1111486T1 (el)	2015-08-05	Μιμητικα αντισωματα (mimetibodies) δεσμευμενα με υποδοχεα μελανοκορτινης, συνθεσεις, μεθοδοι και χρησεις
NO20100724L (no)	2010-05-28	Ledende sementformulering og anvendelse av denne i en bronn
MXPA05007538A (es)	2005-09-21	Gen resistente a aphis gossypii.
TW200604604A (en)	2006-02-01	Light guide plate and backlight system
ATE497991T1 (de)	2011-02-15	Phosphitester enthaltende stabilisatorzusammensetzung
NO20091016L (no)	2009-03-30	Pyridooksazepin-progesteron reseptormodulatorer
ATE543828T1 (de)	2012-02-15	Heteropolynukleotid-duplexe mit purin-purin- paarung
AR054577A1 (es)	2007-06-27	Gen y enzima glucano diquinasa de chlamydomonas reinharft ii almidon modificado sus usos y metodos de produccion
TW200834278A (en)	2008-08-16	Multiplier-divider with error compensation function
DE602007013084D1 (de)	2011-04-21	Neues markiertes oligonukleotid
TW200833903A (en)	2008-08-16	Construction method of combining geogrid rack and concrete
TR200704119A2 (tr)	2009-01-21	Bir toprak işleme makinası
Mori	2007	Engineering Education
DE60334778D1 (de)	2010-12-16	Gewebsspezifische expression
FI20021337L (fi)	2004-01-09	Mustalipeän hiilletys
FR2853906B1 (fr)	2006-04-14	N-desoxyribosyltransferases de lactobacilles, sequences nucleotidiques correspondantes et leurs applications
ATE443929T1 (de)	2009-10-15	Enzymatische brennstoffzelle